HealthcareServices

Losartan Market Trends and Insights: Global Forecast to 2030

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the losartan market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Losartan Market’s size between 2026 and 2030?

The losartan market size has shown consistent expansion in recent years. It is anticipated to increase from $1.49 billion in 2025 to $1.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. Historically, this growth can be ascribed to several factors, including the escalating global prevalence of hypertension, broad clinical acceptance of ARBs, a rise in the occurrence of diabetes-related kidney disease, heightened awareness in managing cardiovascular risk, and an early transition from ACE inhibitors to ARBs.

The losartan market size is anticipated to experience consistent expansion over the upcoming years. It is projected to reach $1.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. This expansion during the forecast period can be primarily attributed to several factors, including the increasing aging population, a growing need for kidney-protective antihypertensive medications, wider availability of inexpensive generic drugs, a heightened emphasis on preventing strokes, and greater healthcare expenditure dedicated to managing chronic illnesses. Key trends anticipated within this period encompass the increasing prevalence of hypertension and cardiovascular conditions, a developing preference for ARBs over ACE inhibitors, the broader uptake of generic losartan prescriptions, its growing application in the management of diabetic nephropathy, and the rising adoption of long-term blood pressure control therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Drivers Are Shaping Strategic Decisions In The Losartan Market?

An increasing incidence of hypertension is anticipated to propel the expansion of the losartan market in the future. Hypertension is defined as a condition characterized by persistently elevated blood pressure, which can heighten the probability of heart disease, stroke, and other severe health complications. The rising occurrence of hypertension is linked to diets abundant in salt and processed foods, leading to fluid retention and increased strain on the heart. Losartan aids in controlling hypertension by blocking angiotensin II, a hormone that constricts blood vessels. This mechanism helps relax and widen the vessels, effectively lowering blood pressure and easing the heart’s workload. For instance, in January 2025, according to the Centers for Disease Control and Prevention, a US-based organisation, in 2023, high blood pressure served as a primary or contributing factor in 664,470 deaths in the United States. Therefore, the growing prevalence of hypertension is fueling the growth of the losartan market.

What Segment Categories Are Covered In The Losartan Market?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

What Long-Term Trends Are Expected To Shape The Future Of The Losartan Market?

Leading companies in the losartan market are concentrating on developing innovative products and securing approvals, such as for losartan potassium oral suspension, to enhance patient compliance and broaden therapeutic applications. Losartan potassium oral suspension is a liquid form of losartan potassium medication, specifically designed for individuals who have difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, obtained Food and Drug Administration (FDA) approval for Arbli. It is a ready-to-use liquid formulation for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. This product offers precise dosing without compounding and is provided as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Which Major Firms Are Strengthening Their Position In The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Losartan Market?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Losartan Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Liraglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Lysine Market Report 2026

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Market Report 2026

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795